Healthcare >> CEO Interviews >> September 14, 2001

Elliot Hahn – Andrx Corporation (adrx)

Elliot F. Hahn, PhD , is President and a director of Andrx. From June 1990 to February 1993, Dr. Hahn was employed as Vice President, Scientific Affairs of IVAX, where he was involved in the evaluation and international licensing of product opportunities and was responsible for maintaining the intellectual property of IVAX. From 1988 to 1993, Dr. Hahn also served as the Vice President of Research of Baker Norton Pharmaceuticals, a subsidiary of IVAX. Prior to that, he was an Associate Professor at The Rockefeller University from 1977 to 1988. From 1976 until 1978, Dr. Hahn was an Assistant Professor at Albert Einstein College of Medicine and a member of the Institute for Steriod Research at Montefiore Hospital in New York City. Since 1988, he has been an adjunct Associate Professor at the University of Miami School of Medicine. He currently serves on the board of several pharmaceutical/medical companies. Dr. Hahn holds a BS degree from City College scientific papers and is named as an inventor in a number of United States patents. Profile
TWST: We'd like to begin with a brief overview of the history and

evolution of Andrx Corporation?

Dr. Hahn: Andrx was founded in late 1992 by Alan Cohen, our co-Chairman

and Chief Executive